European Journal of Biomedical and Pharmaceutical Sciences

COVID-19 PATHOLOGY AND VITAMIN D NANOEMULSION AS PREVENTIVE AND ALTERNATIVE REMEDIATION FOR SEVERITY: A REVIEW

Zoraida P. Aguilar*, Enaya Alhashim and Vayle Hope R. Benedict

ABSTRACT

Today, CoVID-19 has infected 3,635,483 worldwide and has claimed the lives of 251,577 people and it continues to affect more lives. To date, no drug has been completely tested for the disease and prospective vaccines are still being studied. Meanwhile, various parts of the world have shown positive results using Vitamin D as a possible cure and preventive measure for viral infection including CoVID-19 because of its immune modulation participation in both the innate and adaptive immunity both of which influence pathogen invasion. Clinical studies have shown that the overwhelming host immune response to the CoVID-19 that may be responsible for the severity and mortality could be regulated with Vitamin D which has been shown to modulate inflammatory responses during viral infection. Nanoemulsions of vitamin D could be potentially more effective as preventive and alternative remediation for CoVID-19 severity.

Keywords: CoVID-19, Coronavirus, vitamin D, nanoemulsion.